In Person

Join Cooley at the 2022 BIO International Convention

June 10 – 14, 2022
San Diego Convention Center – 111 W Harbor Dr
Event details
June 10 – 14, 2022
12:00 am
San Diego Convention Center – 111 W Harbor Dr
San Diego, CA

Event summary

BIO is back this year offering ample opportunities to connect with peers and those who can help you achieve your business goals. Cooley is proud to once again chair the digital health track at the BIO International Convention.

Details and registration

Featured agenda items

June 10 – 12, 2022 

Advanced Business Development 

Advanced Business Development (ABD) is designed for executives and business development professionals looking to hone their skills and network with other dealmakers. This long-running course incorporates lectures from experienced dealmakers, review of example models, dissection of actual deals, interaction with other participants and live Q&A. It also includes a mock negotiation scenario when each participant is a member of a deal team assigned to negotiate a transaction involving a drug in development with another team using an actual valuation and deal structuring model.  


  • Joseph Dillon – President and CEO, SynerPhysics and President, Dillon Capital Strategies
  • Patrick Duxbury – Partner, Head of Life Sciences (UK), Gowling WLG
  • Kenneth Krisko – Partner, Cooley  
  • Lesley Stolz – Regional Vice President, Early Innovation Partnering, Johnson & Johnson Innovation
Featured digital health sessions


Tuesday, June 14, 2022: 11:00 am – 12:00 pm PDT

Monetizing AI & Machine Learning Applications in Life Sciences

Life sciences and healthcare companies are leveraging machine learning and AI for new advancements. Join senior executives and dealmakers from 23andMe and leading biotechnology and biopharma companies to learn how they are successfully commercializing and implementing monetization strategies surrounding AI and machine learning. Discussion topics will include dealmaking considerations as well as licensing, data and regulatory issues associated with the technology.


  • Debbie Alexander – Director, Business Development, 23andMe
  • Mark DePristo – CEO and Co-Founder, BigHat Biosciences
  • Kate Hillier – Partner, Cooley
  • David Morgan ll – President and CEO, Zephyr AI
  • Akshay Nanduri – CEO and Founder, Onc.AI

Tuesday, June 14, 2022: 1:45 – 2:45 pm PDT

Partnering Strategies for Success in Digital Health

Strategic partnerships are critical for driving digital health innovation forward. Join us for an in-depth discussion to hear how digital health companies are partnering with leading players ad pharmaceutical companies and to enhance patients’ healthcare experience and improve outcomes. These partnerships showcase how the continuum of care is evolving, from digital companion applications to chronic disease management.


  • Wainwright Fishburn – Partner and Global Chair, Digital Health, Cooley
  • Brad Gescheider  Global Head-Digital Innovation and Patient Services, Immunology, Sanofi
  • James Lu – CEO and Co-founder, Helix
  • Kal Patel – CEO and Co-founder, BrightInsight

Tuesday, June 14, 2022: 3:00 – 4:00 pm PDT

Investors' Perspectives – Digital Health Trends and Investment Thesis in 2022 and Beyond

Join this panel of the leading investors in digital health to learn more about the 2022 investment landscape. Learn what drives early and late stage investment decisions and how best to position your company for success in the current market.


  • Nate BayorManaging Director and Partner, BCG Digital Ventures
  • Robert Garber – Partner, 7wireVentures
  • Dan Gebremedhin – Partner, Flare Capital
  • Josh Seidenfeld – Partner, Cooley

For more information, please email Ilana Brand.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.